Endocrinology & Metabolism Department, Renmin Hospital of Wuhan University, Wuhan, China.
Vascular Surgery Department, Renmin Hospital of Wuhan University, Wuhan, China.
Oxid Med Cell Longev. 2018 Apr 3;2018:6306542. doi: 10.1155/2018/6306542. eCollection 2018.
Abdominal aortic aneurysm (AAA) was previously ascribed to weaken defective medial arterial/adventitial layers, for example, smooth muscle/fibroblast cells. Therefore, besides surgical repair, medications targeting the medial layer to strengthen the aortic wall are the most feasible treatment strategy for AAA. However, so far, it is unclear whether such drugs have any beneficial effect on AAA prognosis, rate of aneurysm growth, rupture, or survival. Notably, clinical studies have shown that AAA is highly associated with endothelial dysfunction in the aged population. Additionally, animal models of endothelial dysfunction and endothelial nitric oxide synthase (eNOS) uncoupling had a very high rate of AAA formation, indicating there is crucial involvement of the endothelium and a possible pharmacological solution targeting the endothelium in AAA treatment. Endothelial cells have been found to trigger vascular wall remodeling by releasing proteases, or recruiting macrophages along with other neutrophils, into the medial layer. Moreover, inflammation and oxidative stress of the arterial wall were induced by endothelial dysfunction. Interestingly, there is a paradoxical differential correlation between diabetes and aneurysm formation in retinal capillaries and the aorta. Deciphering the significance of such a difference may explain current unsuccessful AAA medications and offer a solution to this treatment challenge. It is now believed that AAA and atherosclerosis are two separate but related diseases, based on their different clinical patterns which have further complicated the puzzle. Therefore, a thorough investigation of the interaction between endothelium and medial/adventitial layer may provide us a better understanding and new perspective on AAA formation, especially after taking into account the importance of endothelium in the development of AAA. Moreover, a novel medication strategy replacing the currently used, but suboptimal treatments for AAA, could be informed with this analysis.
腹主动脉瘤(AAA)以前归因于动脉中层/外膜层的缺陷和弱化,例如平滑肌/成纤维细胞。因此,除了手术修复外,针对中层的药物治疗以增强主动脉壁是 AAA 最可行的治疗策略。然而,到目前为止,尚不清楚这些药物是否对 AAA 的预后、瘤体生长速度、破裂或生存率有任何有益影响。值得注意的是,临床研究表明,AAA 与老年人群中的内皮功能障碍高度相关。此外,内皮功能障碍和内皮型一氧化氮合酶(eNOS)解偶联的动物模型中 AAA 的形成率非常高,这表明内皮在 AAA 的治疗中有重要作用,并且可能有针对内皮的药理学解决方案。内皮细胞通过释放蛋白酶或招募巨噬细胞和其他中性粒细胞进入中层,触发血管壁重塑。此外,动脉壁的炎症和氧化应激是由内皮功能障碍引起的。有趣的是,糖尿病与视网膜毛细血管和主动脉中的动脉瘤形成之间存在矛盾的差异相关性。解析这种差异的意义可能可以解释当前 AAA 药物治疗的失败,并为这一治疗挑战提供解决方案。现在认为,AAA 和动脉粥样硬化是两种独立但相关的疾病,基于它们不同的临床模式,这进一步使问题复杂化。因此,深入研究内皮细胞与中层/外膜层之间的相互作用,可以为我们提供对 AAA 形成的更好理解和新视角,特别是在考虑到内皮细胞在 AAA 发展中的重要性之后。此外,这种分析可以为 AAA 提供一种新的药物治疗策略,替代目前使用的但效果不佳的治疗方法。